| Breakdown | TTM | Mar 2025 | Mar 2024 | Mar 2023 | Mar 2022 | Mar 2021 |
|---|---|---|---|---|---|---|
Income Statement | ||||||
| Total Revenue | 41.90B | 43.33B | 41.15B | 37.86B | 35.51B | 34.37B |
| Gross Profit | 8.72B | 9.56B | 8.69B | 7.19B | 6.40B | 6.32B |
| EBITDA | 6.50B | 7.23B | 6.54B | 5.32B | 4.44B | 4.08B |
| Net Income | 3.78B | 4.28B | 3.92B | 2.93B | 2.70B | 2.28B |
Balance Sheet | ||||||
| Total Assets | 34.60B | 38.21B | 37.62B | 37.07B | 35.90B | 34.51B |
| Cash, Cash Equivalents and Short-Term Investments | 20.58B | 22.62B | 20.74B | 20.94B | 19.33B | 17.30B |
| Total Debt | 7.84B | 5.29B | 8.76B | 12.42B | 15.88B | 15.93B |
| Total Liabilities | 15.18B | 15.27B | 18.11B | 20.97B | 22.31B | 22.54B |
| Stockholders Equity | 19.42B | 22.93B | 19.51B | 16.11B | 13.58B | 11.98B |
Cash Flow | ||||||
| Free Cash Flow | 3.27B | 6.00B | 3.77B | 5.31B | 1.87B | 3.20B |
| Operating Cash Flow | 3.55B | 6.27B | 4.21B | 5.60B | 2.74B | 3.88B |
| Investing Cash Flow | -74.15M | 54.55M | -162.96M | -6.40M | 411.66M | 413.00M |
| Financing Cash Flow | -2.97B | -4.45B | -4.24B | -3.98B | -1.11B | 1.98B |
Name | Overall Rating | Market Cap | P/E Ratio | ROE | Dividend Yield | Revenue Growth | EPS Growth |
|---|---|---|---|---|---|---|---|
74 Outperform | ¥55.11B | 13.44 | ― | 1.68% | 5.30% | 9.07% | |
70 Outperform | ¥17.48B | 16.51 | ― | 1.49% | 0.06% | 5.50% | |
63 Neutral | $10.79B | 15.43 | 7.44% | 2.01% | 2.89% | -14.66% | |
61 Neutral | ¥34.34B | 18.14 | ― | 2.59% | 0.68% | 33.74% | |
60 Neutral | ¥66.07B | 10.29 | ― | 2.18% | 6.54% | 140.15% | |
56 Neutral | ¥6.17B | 16.24 | ― | 2.29% | -0.18% | -65.47% | |
54 Neutral | ¥16.72B | 30.45 | ― | 1.13% | 3.36% | -15.06% |